A detailed history of Alpha Core Capital LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Alpha Core Capital LLC holds 13,024 shares of JNJ stock, worth $1.9 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
13,024
Previous 13,065 0.31%
Holding current value
$1.9 Million
Previous $2.05 Million 0.64%
% of portfolio
0.56%
Previous 0.31%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$155.22 - $162.74 $6,364 - $6,672
-41 Reduced 0.31%
13,024 $2.06 Million
Q4 2023

Feb 13, 2024

SELL
$145.6 - $158.88 $18,200 - $19,860
-125 Reduced 0.95%
13,065 $2.05 Million
Q3 2023

Nov 13, 2023

BUY
$155.75 - $174.48 $76,006 - $85,146
488 Added 3.84%
13,190 $2.05 Million
Q2 2023

Aug 09, 2023

BUY
$154.35 - $166.11 $255,912 - $275,410
1,658 Added 15.01%
12,702 $2.1 Million
Q1 2023

May 11, 2023

BUY
$151.05 - $180.26 $431,096 - $514,462
2,854 Added 34.85%
11,044 $1.71 Million
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $173,496 - $194,712
1,083 Added 15.24%
8,190 $1.45 Million
Q3 2022

Nov 09, 2022

BUY
$161.33 - $179.52 $202,146 - $224,938
1,253 Added 21.4%
7,107 $1.16 Million
Q2 2022

Aug 12, 2022

BUY
$168.19 - $186.01 $74,508 - $82,402
443 Added 8.19%
5,854 $1.04 Million
Q1 2022

May 04, 2022

BUY
$158.14 - $179.59 $634,932 - $721,053
4,015 Added 287.61%
5,411 $959,000
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $16,996 - $18,858
-109 Reduced 7.24%
1,396 $239,000
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $243,057 - $270,102
1,505 New
1,505 $243,000
Q3 2020

Nov 05, 2020

SELL
$140.38 - $153.83 $86,614 - $94,913
-617 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$128.81 - $155.51 $33,490 - $40,432
-260 Reduced 29.65%
617 $87,000
Q1 2020

May 04, 2020

BUY
$111.14 - $153.99 $97,469 - $135,049
877 New
877 $115,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $382B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Alpha Core Capital LLC Portfolio

Follow Alpha Core Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Core Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Core Capital LLC with notifications on news.